Microglia in Alzheimer's disease at single-cell level. Are there common patterns in humans and mice?
Alzheimer's disease (AD) is characterized by extracellular aggregates of amyloid β peptides,
intraneuronal tau aggregates, and neuronal death. This pathology triggers activation of …
intraneuronal tau aggregates, and neuronal death. This pathology triggers activation of …
Alzheimer's disease and its treatment by different approaches: A review
Alzheimer's disease (AD) is a neurodegenerative disorder that impairs mental ability
development and interrupts neurocognitive function. This neuropathological condition is …
development and interrupts neurocognitive function. This neuropathological condition is …
Pathological mechanisms and therapeutic strategies for Alzheimer's disease
Y Ju, KY Tam - Neural Regeneration Research, 2022 - journals.lww.com
Alzheimer's disease is a rather complex neurodegenerative disease, which is attributed to a
combination of multiple factors. Among the many pathological pathways, synaptic …
combination of multiple factors. Among the many pathological pathways, synaptic …
Advances in the development of new biomarkers for Alzheimer's disease
TO Klyucherev, P Olszewski, AA Shalimova… - Translational …, 2022 - Springer
Alzheimer's disease (AD) is a complex, heterogeneous, progressive disease and is the most
common type of neurodegenerative dementia. The prevalence of AD is expected to increase …
common type of neurodegenerative dementia. The prevalence of AD is expected to increase …
[HTML][HTML] The pharmacological action of kaempferol in central nervous system diseases: a review
J Silva dos Santos, JP Goncalves Cirino… - Frontiers in …, 2021 - frontiersin.org
Kaempferol (KPF) is a flavonoid antioxidant found in fruits and vegetables. Many studies
have described the beneficial effects of dietary KPF in reducing the risk of chronic diseases …
have described the beneficial effects of dietary KPF in reducing the risk of chronic diseases …
[HTML][HTML] Nanotechnology: a promising approach for delivery of neuroprotective drugs
Central nervous system (CNS) disorders especially neurodegenerative disorders are the
major challenge for public health and demand the great attention of researchers to protect …
major challenge for public health and demand the great attention of researchers to protect …
Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions
A Abeysinghe, R Deshapriya, C Udawatte - Life sciences, 2020 - Elsevier
Alzheimer's disease (AD) is a neurodegenerative disorder and is identified as the most
common cause for dementia. Despite huge global economic burden and the impact on the …
common cause for dementia. Despite huge global economic burden and the impact on the …
Emerging applications of nanotechnology in healthcare systems: Grand challenges and perspectives
Healthcare, as a basic human right, has often become the focus of the development of
innovative technologies. Technological progress has significantly contributed to the …
innovative technologies. Technological progress has significantly contributed to the …
The neuropathological diagnosis of Alzheimer's disease
MA DeTure, DW Dickson - Molecular neurodegeneration, 2019 - Springer
Alzheimer's disease is a progressive neurodegenerative disease most often associated with
memory deficits and cognitive decline, although less common clinical presentations are …
memory deficits and cognitive decline, although less common clinical presentations are …
Role of oxidative stress in Alzheimer's disease
WJ Huang, XIA Zhang, WW Chen - Biomedical reports, 2016 - spandidos-publications.com
Alzheimer's disease (AD) is the most common cause of disability in individuals aged> 65
years worldwide. AD is characterized by the abnormal deposition of amyloid β (Aβ) peptide …
years worldwide. AD is characterized by the abnormal deposition of amyloid β (Aβ) peptide …